Bill
HB 2176
Exempting information in collaborative drug therapy agreements from disclosure under the public records act.
2025-2026 Regular Session
Introduced by Mary Fosse and 7 co-sponsors
HB 2176 exempts collaborative drug therapy agreements from public records disclosure, shielding pharmacist-physician protocols from transparency requirements but potentially limiting oversight of publicly-funded healthcare arrangements.
House Rules "X" file.